"
Team:SYSU-China/Project/Results
From 2013.igem.org
Sympathetic (Talk | contribs) |
|||
| Line 35: | Line 35: | ||
<span>UPDATE <INS>09/22/2013</INS></span> | <span>UPDATE <INS>09/22/2013</INS></span> | ||
<h1>Overview of result</h1> | <h1>Overview of result</h1> | ||
| - | + | <p>Our experimental results are presented by two lines. One is the test for each part, the other is the test in each period of cells. </p> | |
| + | <h2>Test for each part </h2> | ||
<p> | <p> | ||
Our iPSC safeguard consists of three devices: the suicide gene, the miR-122 target and the Tet-off system. Candidates of each device were cloned and characterized. For Suicide Gene, RIP1 and RIP3 has optimal lethal effect in both HEK293 and HepG2 while apoptin can only kill HepG2. MiR-122 target can sensitively regulate gene expression as GFP level negatively correlates with exogenous level of miR-122 transected to HEK293. Tet-off system with pTight and tTA shows a low leakage expression level and medium full expression level. Differential equations were employed to analyze and predict the performance of the pathway.</p> | Our iPSC safeguard consists of three devices: the suicide gene, the miR-122 target and the Tet-off system. Candidates of each device were cloned and characterized. For Suicide Gene, RIP1 and RIP3 has optimal lethal effect in both HEK293 and HepG2 while apoptin can only kill HepG2. MiR-122 target can sensitively regulate gene expression as GFP level negatively correlates with exogenous level of miR-122 transected to HEK293. Tet-off system with pTight and tTA shows a low leakage expression level and medium full expression level. Differential equations were employed to analyze and predict the performance of the pathway.</p> | ||
| Line 50: | Line 51: | ||
| - | + | <h2>Test in different cells </h2> | |
<p> | <p> | ||
After prove of function, the pathway was packaged into lentivirus to test the performance in our three destiny cell types: iPSCs, hepatocytes and hepatomas. So far, we have successfully generated Oct4-GFP miPSCs with pluripotency verified. All three suicide genes have significant lethal effects in iPSCs and HepG2. With pathway integrated into the genome by lentivirus, leakage expression of TRE3G is low enough to be safe, but the pTight does not work well. Doxycycline has no obvious side effects to iPSC. Stable cell line with both TRE3G and tTA requires a little more time to finish the second round of selection and we are still waiting for result of teratoma formation from our stable iPSCs. | After prove of function, the pathway was packaged into lentivirus to test the performance in our three destiny cell types: iPSCs, hepatocytes and hepatomas. So far, we have successfully generated Oct4-GFP miPSCs with pluripotency verified. All three suicide genes have significant lethal effects in iPSCs and HepG2. With pathway integrated into the genome by lentivirus, leakage expression of TRE3G is low enough to be safe, but the pTight does not work well. Doxycycline has no obvious side effects to iPSC. Stable cell line with both TRE3G and tTA requires a little more time to finish the second round of selection and we are still waiting for result of teratoma formation from our stable iPSCs. | ||
Revision as of 21:40, 27 September 2013
ipsc
Overview of result
Our experimental results are presented by two lines. One is the test for each part, the other is the test in each period of cells.
Test for each part
Our iPSC safeguard consists of three devices: the suicide gene, the miR-122 target and the Tet-off system. Candidates of each device were cloned and characterized. For Suicide Gene, RIP1 and RIP3 has optimal lethal effect in both HEK293 and HepG2 while apoptin can only kill HepG2. MiR-122 target can sensitively regulate gene expression as GFP level negatively correlates with exogenous level of miR-122 transected to HEK293. Tet-off system with pTight and tTA shows a low leakage expression level and medium full expression level. Differential equations were employed to analyze and predict the performance of the pathway.
If you want to see the results for testing each parts, please click the following wheer gears.
Test in different cells
After prove of function, the pathway was packaged into lentivirus to test the performance in our three destiny cell types: iPSCs, hepatocytes and hepatomas. So far, we have successfully generated Oct4-GFP miPSCs with pluripotency verified. All three suicide genes have significant lethal effects in iPSCs and HepG2. With pathway integrated into the genome by lentivirus, leakage expression of TRE3G is low enough to be safe, but the pTight does not work well. Doxycycline has no obvious side effects to iPSC. Stable cell line with both TRE3G and tTA requires a little more time to finish the second round of selection and we are still waiting for result of teratoma formation from our stable iPSCs.
If you want to see the results testing iPSCs in different periods, please click the following cute cells.
Sun Yat-Sen University, Guangzhou, China
Address: 135# Xingang Rd.(W.), Haizhu Guangzhou, P.R.China
